ONTOLOGY REPORT - ANNOTATIONS
| Term: | 2-methoxy-17beta-estradiol |
|
| Accession: | CHEBI:28955
|
browse the term
|
| Definition: | A 17beta-hydroxy steroid, being 17beta-estradiol methoxylated at C-2. |
| Synonyms: | exact_synonym: | 2-methoxyestra-1,3,5(10)-triene-3,17beta-diol |
| | related_synonym: | 1,3,5(10)-ESTRATRIEN-2,3,17-BETA-TRIOL 2-METHYL ETHER; 2-Hydroxyestradol 2-methyl ether; 2-Methoxyestradiol-17beta; 2-methoxyestradiol; C19H26O3; InChI=1S/C19H26O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,18,20-21H,3-8H2,1-2H3/t12-,13+,15-,18-,19-/m0/s1; InChIKey=CQOQDQWUFQDJMK-SSTWWWIQSA-N; Panzem; [H][C@]12CC[C@]3(C)[C@@H](O)CC[C@@]3([H])[C@]1([H])CCc1cc(O)c(OC)cc21 |
| | alt_id: | CHEBI:1187; CHEBI:19675; CHEBI:42274 |
| | xref_casrn: | 362-07-2 |
| | xref: | ChEMBL:173421 "ChEMBL COMPOUND"; ChemIDplus:362-07-2 "CAS Registry Number"; CiteXplore:12543804 "PubMed citation"; CiteXplore:16828472 "PubMed citation"; CiteXplore:16969706 "PubMed citation"; CiteXplore:18566218 "PubMed citation"; CiteXplore:19228747 "PubMed citation"; CiteXplore:19577796 "PubMed citation"; CiteXplore:20499131 "PubMed citation"; CiteXplore:20960192 "PubMed citation"; CiteXplore:9018099 "PubMed citation"; KEGG COMPOUND:362-07-2 "CAS Registry Number"; KEGG COMPOUND:C05302 "KEGG COMPOUND"; LIPID MAPS:LMST02010035 "LIPID MAPS instance" |
| | xref_mesh: | MESH:C022830 |
| | xref: | Patent:CA2499254 "Patent"; Patent:CN1672746 "Patent"; Patent:JP2005270658 "Patent"; Patent:US2009104246 "Patent"; Reaxys:3147966 "Reaxys Registry Number" |
|
|
2-methoxy-17beta-estradiol
|
| G |
CCNB1 |
cyclin B1 |
|
multiple interactions |
EXP |
5 |
68,462,837 |
68,474,072 |
RGD:6480464 |
CTD |
| G |
COMT |
catechol-O-methyltransferase |
|
affects chemical synthesis |
EXP |
22 |
19,929,263 |
19,957,498 |
RGD:6480464 |
CTD |
| G |
CTF1 |
cardiotrophin 1 |
|
multiple interactions |
ISO |
16 |
30,907,928 |
30,914,881 |
RGD:6480464 |
CTD |
| G |
CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa |
|
decreases expression |
EXP |
3 |
41,240,942 |
41,281,939 |
RGD:6480464 |
CTD |
| G |
CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa |
|
multiple interactions |
EXP |
3 |
41,240,942 |
41,281,939 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
increases abundance |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
HSD17B2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
multiple interactions |
EXP |
16 |
82,068,858 |
82,132,139 |
RGD:6480464 |
CTD |
| G |
HSD17B2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
decreases response to substance |
EXP |
16 |
82,068,858 |
82,132,139 |
RGD:6480464 |
CTD |
| G |
PRDX4 |
peroxiredoxin 4 |
|
increases expression |
EXP |
X |
23,685,645 |
23,704,514 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
affects response to substance |
EXP |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
increases response to substance |
EXP |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SULT1A1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
increases sulfation |
EXP |
16 |
28,616,908 |
28,634,907 |
RGD:6480464 |
CTD |
| G |
SULT1A1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
affects sulfation |
EXP |
16 |
28,616,908 |
28,634,907 |
RGD:6480464 |
CTD |
| G |
TUBB4A |
tubulin, beta 4A class IVa |
|
decreases expression |
EXP |
19 |
6,494,330 |
6,502,330 |
RGD:6480464 |
CTD |
| G |
UGT1A1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases glucuronidation |
EXP |
2 |
234,668,919 |
234,681,945 |
RGD:6480464 |
CTD |
| G |
UGT1A10 |
UDP glucuronosyltransferase 1 family, polypeptide A10 |
|
increases glucuronidation |
EXP |
2 |
234,545,123 |
234,681,951 |
RGD:6480464 |
CTD |
| G |
UGT1A3 |
UDP glucuronosyltransferase 1 family, polypeptide A3 |
|
increases glucuronidation |
EXP |
2 |
234,637,773 |
234,681,945 |
RGD:6480464 |
CTD |
| G |
UGT1A7 |
UDP glucuronosyltransferase 1 family, polypeptide A7 |
|
increases glucuronidation |
EXP |
2 |
234,590,584 |
234,681,945 |
RGD:6480464 |
CTD |
| G |
UGT1A8 |
UDP glucuronosyltransferase 1 family, polypeptide A8 |
|
increases glucuronidation |
EXP |
2 |
234,526,291 |
234,681,945 |
RGD:6480464 |
CTD |
| G |
UGT1A9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
increases glucuronidation |
EXP |
2 |
234,580,544 |
234,681,951 |
RGD:6480464 |
CTD |
| G |
XIAP |
X-linked inhibitor of apoptosis |
|
decreases expression |
EXP |
X |
122,993,662 |
123,047,829 |
RGD:6480464 |
CTD |
Term paths to the root
|